Status:
NOT_YET_RECRUITING
FET in Adenomyosis
Lead Sponsor:
Indira IVF Hospital Pvt Ltd
Conditions:
Adenomyosis
Eligibility:
FEMALE
21-42 years
Phase:
NA
Brief Summary
Purpose of the Study: To compare the effectiveness of GnRH agonist downregulation alone versus GnRH agonist combined with letrozole in improving pregnancy outcomes in women with adenomyosis undergoin...
Eligibility Criteria
Inclusion
- Diagnosis of adenomyosis confirmed via transvaginal ultrasound as per MUSA criteria History of infertility requiring frozen embryo transfer (FET). Availability of at least one good-quality frozen embryo for transfer
Exclusion
- BMI ≥ 30 kg/m2 Presence of endocrine disorders; (uncontrolled diabetes mellitus, / hyperprolactinemia, thyroid dysfunction, Congenital adrenal hyperplasia, Cushing syndrome, or polycystic ovary syndrome Previous major uterine surgery Gestational carrier Fertility preservation
Key Trial Info
Start Date :
June 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 23 2026
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT06913075
Start Date
June 25 2025
End Date
January 23 2026
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indira IVF Pvt Hospital
Udaipur, Rajasthan, India, 313001